Stem cells are undifferentiated cells that are able to differentiate into specialized cell types. Stem cells come from two main sources:

1. Embryos formed during the blastocyst phase of embryological development (embryonic stem cells)
2. Adult tissue (adult stem cells).

Both types are generally characterized by their potency, or potential to differentiate into different cell types (such as skin, muscle, bone, etc.).

The global stem cells market size is expected to reach USD 170.15 billion by 2020, according to a recently published report. The main reasons behind the sharp growth is increasing research and development to develop therapeutic solution for chronic diseases and the huge funding by the government for drug discovery and development to serve the large unmet medical needs. And rising approvals of clinical trials for stem cell therapy are other factors that are propelling the growth of the market.

Based on the therapeutic applications, the global stem cell therapy market is segmented into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others. The Central Nervous System (CNS) disease segment will be the fastest-growing segment of the global market in the forecast period.

The several dominant market players have utilized acquisition strategies to grow and capture market share, Merck KGaA had a particularly strong commitment to this approach and acquired several other major players within the stem cell research products marketplace, including Milllipore on February 26, 2010, for $7.2 billion, and Sigma-Aldrich on September 22, 2014, for $17 billion.

Study includes in which Asia-Pacific is expected to be the fastest growing segment with a CAGR of over 25.0% due to rising contract research outsourcing and medical tourism. Key industry contributors include Advanced Cell Technology, CellartisAB, Cellular Engineering Technologies, BioTime and International Stem Cell Corporation.

Stem Cell Technology – Objective

Major Competitors

Presentation will provide market revenue ,major M&A and other market details of the following competitors:

1. Miltenyi Biotec
2. Thermo Fisher Scientific
3. BD Biosciences
4. Merck KGaA
5. STEMCELL Technologies

About Effectual Services

Effectual Services is an award-winning Intellectual Property (IP) management advisory & consulting firm offering IP intelligence to Fortune 500 companies, law firms, research institutes and universities, and venture capital firms/PE firms, globally. Through research & intelligence we help our clients in taking critical business decisions backed with credible data sources, which in turn helps them achieve their organisational goals, foster innovation and achieve milestones within timelines while optimising costs.

We are one of the largest IP & business intelligence providers, globally serving clients for over a decade now. Our multidisciplinary teams of subject matter experts have deep knowledge of best practices across industries, are adept with benchmarking quality standards and use a combination of human and machine intellect to deliver quality projects. Having a global footprint in over 5 countries helps us to bridge boundaries and work seamlessly across multiple time zones, thus living to the core of our philosophy - Innovation is global, so are we !!!

Follow Us: LinkedIn, Twitter